ArticlePatient preference and adherence2025
Acceptance of the Istel Care Telehealth System by Women with Gestational Diabetes (GDM) in Routine Care in Poland.
Article in Patient preference and adherence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Currently, telehealth, which encompasses digital tools such as video communication, mobile applications, and remote monitoring, enables professional remote education and medical care. This study aimed to assess the acceptance of telehealth care by women with Gestational Diabetes Mellitus (GDM) in routine care based on data from the Istel Care system. Material and Methods: This retrospective, multicenter observational study included 62 patients from three clinical centers: 44 from Krakow, 10 from Rzeszow, and 8 from Zabrze. Patients who consented to participate in the research and conduct home measurements as recommended received a glucometer, a blood pressure monitor, a scale, and a mobile application integrated with the telemedicine Istel Care System. Only the first visit was face-to-face, and the rest were online. After the study, patients completed a satisfaction questionnaire using the Istel Care System. Results: Of the 62 participants, 58 completed the study, and 50 responded to the follow-up survey. Satisfaction was high across several areas, including convenience (8.7 ± 2.5), accessibility (9.0 ± 2.3), and ease of interpreting results (9.3 ± 1.7). Patients used the system 5-7 times daily, most often seeking information on gestational diabetes and dietary advice. The most valued feature was the ability to easily share measurements with their doctor (89.8%), while 76.9% reported improved communication with their healthcare provider. Reported challenges included technological barriers (45.7%) and concerns about data security (21.6%). Suggested improvements included measurement reminders and real-time feedback from professionals. Overall, the system was positively received, enhancing patient control and motivation for lifestyle changes. Conclusion: The Istel Care telehealth system was well accepted and feasible for women with GDM in routine care, supporting effective communication and patient self-management.These findings encourage further evaluation of telehealth solutions in diabetes care under routine clinical conditions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.